Hemoglobin regulates the metabolic and synthetic function of rat insulinoma cells cultured in a hollow fiber bioreactor

Biotechnology and Bioengineering

Volumn 107, Issue 3, 2010, Pages 582-592

  Gundersen, Sharon I ^a   Chen, Guo ^a   Powell, Heather M ^a   Palmer, Andre F ^a  

^a The Ohio State University   (United States)

Author keywords

Bioartificial; Hollow fiber bioreactor; Insulin; Insulinoma; Oxygen carrier; Pancreas; Tissue engineering

Indexed keywords

BIOARTIFICIAL; HOLLOW FIBER BIOREACTOR; INSULINOMA; OXYGEN CARRIER; PANCREAS;

BIOCONVERSION; BIOREACTORS; FIBERS; GLUCOSE; HEMOGLOBIN; INSULIN; METABOLISM; OXYGEN; OXYGENATION; OXYGENATORS; TISSUE ENGINEERING; RATS;

CELL CULTURE;

HEMOGLOBIN; INSULIN;

ANIMAL CELL; ARTICLE; BIOARTIFICIAL ORGAN; BIOREACTOR; CELL CULTURE; CELL EXPANSION; CONTROLLED STUDY; DIABETIC PATIENT; HOLLOW FIBER REACTOR; INSULIN DEPENDENT DIABETES MELLITUS; INSULINOMA; METABOLIC REGULATION; NONHUMAN; OXYGEN TRANSPORT; OXYGENATION; PANCREAS ISLET TRANSPLANTATION; POLYMERASE CHAIN REACTION; RAT; REGULATORY MECHANISM; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTIFICIAL PANCREAS; CELL METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; BIOREACTORS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CULTURE MEDIA; GENE EXPRESSION PROFILING; HEMOGLOBINS; INSULIN; INSULIN-SECRETING CELLS; OXYGEN; PANCREAS, ARTIFICIAL; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

BOVINAE; RATTUS;

EID: 78651507971     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22830     Document Type: Article

References (39)

1. Ali S, Drucker DJ. 2009. Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes. Am J Physiol Endocrinol Metab 296(3):E415-E421.
2. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB. 1992. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130(1):167-178.
3. Bao S, Bohrer A, Ramanadham S, Jin W, Zhang S, Turk J. 2006. Effects of stable suppression of Group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells. J Biol Chem 281(1):187-198.
4. Beck J, Angus R, Madsen B, Britt D, Vernon B, Nguyen KT. 2007. Islet encapsulation: Strategies to enhance islet cell functions. Tissue Eng 13(3):589-599.
5. Bortolotti C, Kunit T, Moder A, Hufnagl C, Schmidt S, Hartl A, Langelueddecke C, Fürst J, Geibel JP, Ritter M, Jakab M. 2009. The phytostilbene resveratrol induces apoptosis in INS-1E rat insulinoma cells. Cell Physiol Biochem 23(4-6):245-254.
6. Chen G, Palmer AF. 2009. Hemoglobin-based oxygen carrier and convection enhanced oxygen transport in a hollow fiber bioreactor. Biotechnol Bioeng 102(6):1603-1612.
7. Fan MY, Lum ZP, Fu XW, Levesque L, Tai IT, Sun AM. 1990. Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes 39(4):519-522.
8. Fraga DW, Sabek O, Hathaway DK, Gaber AO. 1998. A comparison of media supplement methods for the extended culture of human islet tissue. Transplantation 65(8):1060-1066.
9. Goto T, Tanioka Y, Sakai T, Terai S, Kamoda Y, Li S, Tanaka T, Tsujimura T, Matsumoto I,Fujino Y,Suzuki Y,Kuroda Y. 2007 .Applicationofthe twolayer method on pancreas digestion results in improved islet yield and maintained viability of isolated islets. Transplantation 83(6):754-758.
10. Hogan A, Pileggi A, Ricordi C. 2008. Transplantation: Current developments and future directions; the future of clinical islet transplantation as a cure for diabetes. Front Biosci 13:1192-1205.
11. Hu YH, Wu DQ, Gao F, Li GD, Yao L, Zhang XC. 2009. A secretory function of human insulin-producing cells in vivo. Hepatobiliary Pancreat Dis Int 8(3):255-260.
12. Knaack D, Fiore DM, Surana M, Leiser M, Laurance M, Fusco-DeMane D, Hegre OD, Fleischer N, Efrat S. 1994. Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes 43(12):1413-1417.
13. Lacy PE, Hegre OD, Gerasimidi-Vazeou A, Gentile FT, Dionne KE. 1991. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 254(5039):1782-1784.
14. Lanza RP, Butler DH, Borland KM, Staruk JE, Faustman DL, Solomon BA, Muller TE, Rupp RG, Maki T, Monaco AP, Chick WL. 1991. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci USA 88(24):11100-11104.
15. Lau J, Henriksnas J, Svensson J, Carlsson PO. 2009. Oxygenation of islets and its role in transplantation. Curr Opin Organ Transplant 14(6):688-693.
16. Lucas-Clerc C, Massart C, Campion JP, Launois B, Nicol M. 1993. Long-term culture of human pancreatic islets in an extracellular matrix: Morphological and metabolic effects. Mol Cell Endocrinol 94(1):9-20.
17. Narang AS, Mahato RI. 2006. Biological and biomaterial approaches for improved islet transplantation. Pharmacol Rev 58(2):194-243.
18. Nieuwoudt M, Wiggett S, Malfeld S, van der Merwe SW. 2009. Imaging glucose metabolism in perfluorocarbon-perfused hepatocyte bioreactors using positron emission tomography. J Artif Organs 12(4):247-257.
19. Palmer AF, Sun G, Harris DR. 2009. Tangential flow filtration of hemoglobin. Biotechnol Prog 25(1):189-199.
20. Papas KK, Long RC, Jr., Constantinidis I, Sambanis A. 1996. Effects of oxygen on metabolic and secretory activities of beta TC3 cells. Biochim Biophys Acta 1291(2):163-166.
21. Pileggi A, Ribeiro MM, Hogan AR, Molano RD, Cobianchi L, Ichii H, Embury J, Inverardi L, Fornoni A, Ricordi C, Pastori RL. 2009. Impact of pancreatic cold preservation on rat islet recovery and function. Transplantation 87(10):1442-1450.
22. Pilkis SJ, Claus TH. 1991. Hepatic gluconeogenesis/glycolysis: Regulation and structure/function relationships of substrate cycle enzymes. Annu Rev Nutr 11:465-515.
23. Rihova B. 2000. Immunocompatibility and biocompatibility of cell delivery systems. Adv Drug Deliv Rev 42(1-2):65-80.
24. Rosenberg L, Wang R, Paraskevas S, Maysinger D. 1999. Structural and functional changes resulting from islet isolation lead to islet cell death. Surgery 126(2):393-398.
25. Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliott JF, Bigam D, Kneteman NM, Warnock GL, Larsen I, Shapiro AM. 2001. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50(4):710-719.
26. Ryan EA, Lakey JR, Paty BW, Imes S, Korbutt GS, Kneteman NM, Bigam D, Rajotte RV, Shapiro AM. 2002. Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 51(7):2148-2157.
27. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM. 2005. Five-year follow-up after clinical islet transplantation. Diabetes 54(7):2060-2069.
28. Schmied BM, Ulrich A, Matsuzaki H, Ding X, Ricordi C, Moyer MP, Batra SK, Adrian TE, Pour PM. 2000. Maintenance of human islets in longterm culture. Differentiation 66(4-5):173-180.
29. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343(4):230-238.
30. Soon-Shiong P, Feldman E, Nelson R, Komtebedde J, Smidsrod O, Skjak-Braek G, Espevik T, Heintz R, Lee M. 1992. Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 54(5):769-774.
31. Sullivan JP, Palmer AF. 2006. Targeted oxygen delivery within hepatic hollow fiber bioreactors via supplementation of hemoglobin-based oxygen carriers. Biotechnol Prog 22(5):1374-1387.
32. Sullivan SJ, Maki T, Carretta M, Ozato H, Borland K, Mahoney MD, Muller TE, Solomon BA, Monaco AP, Chick WL. 1992. Evaluation of the hybrid artificial pancreas in diabetic dogs. ASAIO J 38(1):29-33.
33. Sullivan JP, Gordon JE, Palmer AF. 2006. Simulation of oxygen carrier mediated oxygen transport to C3A hepatoma cells housed within a hollow fiber bioreactor. Biotechnol Bioeng 93(2):306-317.
34. Sullivan JP, Gordon JE, Bou-Akl T, Matthew HW, Palmer AF. 2007. Enhanced oxygen delivery to primary hepatocytes within a hollow fiber bioreactor facilitated via hemoglobin-based oxygen carriers. Artif Cells Blood Substit Immobil Biotechnol 35(6):585-606.
35. Sullivan JP, Harris DR, Palmer AF. 2008. Convection and hemoglobinbased oxygen carrier enhanced oxygen transport in a hepatic hollow fiber bioreactor. Artif Cells Blood Substit Immobil Biotechnol 36(4): 386-402.
36. Xiaohui T, Wujun X, Xiaoming D, Xinlu P, Yan T, Puxun T, Xinshun F. 2006. Small intestinal submucosa improves islet survival and function in vitro culture. Transplant Proc 38(5):1552-1558.
37. Yamamoto T, Horiguchi A, Ito M, Nagata H, Ichii H, Ricordi C, Miyakawa S. 2009. Quality control for clinical islet transplantation: Organ procurement and preservation, the islet processing facility, isolation, and potency tests. J Hepatobiliary Pancreat Surg 16(2):131-136.
38. Yoshida T, Okuno A, Izumi M, Takahashi K, Hagisawa Y, Ohsumi J, Fujiwara T. 2008. CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats. Eur J Pharmacol 601(1-3):192-197.
39. Yuan S, Rosenberg L, Paraskevas S, Agapitos D, Duguid WP. 1996. Transdifferentiation of human islets to pancreatic ductal cells in collagen matrix culture. Differentiation 61(1):67-75.